A detailed history of Oppenheimer Asset Management Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 25,228 shares of UTHR stock, worth $9.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
25,228
Previous 25,852 2.41%
Holding current value
$9.1 Million
Previous $8.24 Million 9.78%
% of portfolio
0.11%
Previous 0.11%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$311.04 - $363.55 $194,088 - $226,855
-624 Reduced 2.41%
25,228 $9.04 Million
Q2 2024

Aug 08, 2024

BUY
$228.26 - $319.04 $124,858 - $174,514
547 Added 2.16%
25,852 $8.24 Million
Q1 2024

May 06, 2024

SELL
$210.76 - $249.51 $469,573 - $555,908
-2,228 Reduced 8.09%
25,305 $5.81 Million
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $761,534 - $910,595
-3,544 Reduced 11.4%
27,533 $6.05 Million
Q3 2023

Nov 07, 2023

SELL
$211.82 - $248.24 $275,366 - $322,712
-1,300 Reduced 4.02%
31,077 $7.02 Million
Q2 2023

Aug 02, 2023

SELL
$205.19 - $232.99 $217,501 - $246,969
-1,060 Reduced 3.17%
32,377 $7.15 Million
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $115,014 - $149,131
-540 Reduced 1.59%
33,437 $7.49 Million
Q4 2022

Feb 06, 2023

SELL
$205.95 - $280.43 $80,938 - $110,208
-393 Reduced 1.14%
33,977 $9.45 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $107,139 - $128,677
-527 Reduced 1.51%
34,370 $7.2 Million
Q2 2022

Aug 08, 2022

SELL
$174.81 - $241.14 $113,801 - $156,982
-651 Reduced 1.83%
34,897 $8.22 Million
Q1 2022

May 12, 2022

BUY
$166.16 - $213.96 $409,085 - $526,769
2,462 Added 7.44%
35,548 $6.38 Million
Q4 2021

Feb 02, 2022

SELL
$184.32 - $216.08 $134,922 - $158,170
-732 Reduced 2.16%
33,086 $7.15 Million
Q3 2021

Nov 12, 2021

SELL
$179.86 - $214.88 $139,751 - $166,961
-777 Reduced 2.25%
33,818 $6.24 Million
Q2 2021

Aug 03, 2021

BUY
$170.47 - $211.93 $5.9 Million - $7.33 Million
34,595 New
34,595 $6.21 Million
Q2 2020

Aug 11, 2020

SELL
$92.74 - $125.82 $556 - $754
-6 Closed
0 $0
Q4 2018

Jan 30, 2019

BUY
$101.4 - $128.73 $608 - $772
6 New
6 $1,000
Q4 2017

Feb 07, 2018

SELL
$118.58 - $151.28 $711 - $907
-6 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $687 - $820
6
6 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.